7:30 - 8:00 a.m. - Registration
8:00 - 9:00 a.m. - A Review of Newly Approved Antineoplastic Medications - 2015 (0.1 CEUs)
Application Based; UAN:0047-0000-16-031-L01-P
Instructor: Lisa Narveson, PharmD, NDSU Assistant Professor of Practice
Explain the mechanisms of action for newly approved antineoplastic medications.
Discuss appropriate administration of newly approved antineoplastic medications.
Identify potential adverse effects and monitoring for newly approved antineoplastic medications.
9:00 - 10:00 a.m. - Treatment of HCV in the Era of Direct Antiviral Agents (0.1 CEUs)
Application Based; UAN: 0047-0000-16-029-L01-P
Instructor: Sajid Jalil, MD, MS , Division Chair, Sanford Gastroenterology, Fargo, ND
Define pathology of Hepatitis C.
Discuss the current treatment options for Hepatitis C.
Apply new Hepatitis C treatment guidelines into current practice settings.
10:00 - 10:15 a.m. - Break
10:15 - 11:45 a.m. - Adherence and Monitoring of Hypertensive Patients (0.15 CEUs)
Application Based; UAN: 0047-0000-16-028-L01-P
Instructor: Wendy Brown, PharmD, PA-C, AE-C, NDSU Associate Professor of Practice
Determine patient's medication barriers to adherence.
Optimize accurate vital signs assessment.
11:45 - 12:45 p.m. - Lunch
12:45 - 1:45 p.m. - Pain Management and the Incorporation of CDC Guidelines into Clinical Practice (0.1 CEUs)
Application Based; UAN: 0047-0000-16-027-L01-P
Instructor: Elzie (EJ) Jones, PharmD, Clinical Pharmacy Specialist - Primary Care/Pain Management, Minneapolis VA Healthcare System
Describe the risks associated with chronic opioid use.
Outline future treatment options for pain management and opioid safety.
Analyze the history of opioid use at the Minneapolis VAHCS
Describe current Minneapolis VAHCS pain management programs targeting incoroporation of CDC guidelines into clinical practice.
1:45 - 2:45 p.m. - Prevent an Overdose, Prescribe Naloxone, Protect a Life (0.1 CEUs)
Application Based; UAN: 0047-0000-16-030-L01-P
Instructor: LCDR DeAnne Udby, PharmD, NCPS, Advance Practice Pharmacist, White Earth Service Unit, Indian Health Services, Ogema, MN
Describe the correlation between prescription drug abuse and opioid related overdose.
Identify opioid overdose risk factors and signs and symptoms of opioid overdose.
Discuss the pharmacology use of naloxone as a viable harm reduction strategy.
Define the role of the pharmacist in opioid overdose prevention.
2:45 - 3:00 p.m. - Break
3:00 - 4:00 p.m. - The Role of Pharmacogenetics in Precision Medicine (0.1 CEUs)
Application Based; UAN: 0047-0000-16-032-L01-P
Instructor: Natasha Petry, PharmD, NDSU Assistant Professor of Practice
Explain the benefits of using genetic testing to influence prescribing choices.
Describe the barriers and challenges associated with pharmacogenetics testing.
List examples of drugs that may be affected by pharmacogenetic variations.
Identify resources to guide the prescribing of certain medications based on the patients' genetic makeup.
5:30 p.m. - NDSU Homecoming Parade in Downtown Fargo
More event information is available at ndsu.me/pharm1609.